Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | Signal-omics to fingerprint the impact of antigen engagement in CLL

Adam Linley • 22 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Adam Linley, PhD, University of Liverpool, Liverpool, UK, gives us an overview of his study of signal-omics to fingerprint the impact of antigen engagement and therapy on BCR activation in chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Adam Linley

0:44
CLL: modelling functional differences between sIgM, sIgD and chemokine signalling
Adam Linley • 22 Sep 2019

Related Videos

2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals